APA (7th ed.) Citation

Jr, P. M., KJB, A., CWR, T., & DA, D. (2024). Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: A systematic review. Acta neurologica Belgica, 124(4), 1237. https://doi.org/10.1007/s13760-024-02518-9

Chicago Style (17th ed.) Citation

Jr, Prado MB, Adiao KJB, Turalde CWR, and Dasig DA. "Efficacy and Safety of Intravenous Immunoglobulin Retreatment Amongst Guillain-Barré Syndrome Patients Who Poorly Responded to Initial IVIG Cycle: A Systematic Review." Acta Neurologica Belgica 124, no. 4 (2024): 1237. https://doi.org/10.1007/s13760-024-02518-9.

MLA (9th ed.) Citation

Jr, Prado MB, et al. "Efficacy and Safety of Intravenous Immunoglobulin Retreatment Amongst Guillain-Barré Syndrome Patients Who Poorly Responded to Initial IVIG Cycle: A Systematic Review." Acta Neurologica Belgica, vol. 124, no. 4, 2024, p. 1237, https://doi.org/10.1007/s13760-024-02518-9.